Faculty

Institution

Unit

Venue

Cynthia E. Herzog

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Genetics

Department Of Pediatric Research

Department Of Pediatrics Patient Care

The University of Texas MD Anderson Cancer Center

NoneCynthia E. Herzog is currently serving as a Clinical Cancer Genetics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Cynthia E. Herzog

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology radiation oncology sarcoma pathology pediatrics cancer research medicine surgical oncology cancer treatment malignant disease cancer care pharmacotherapy jama oncology clinical research gynecologic oncology surgical pathology tumor biology anatomical pathology cancer discovery tumoral pathology hematological malignancies neuro-oncology molecular cancer leukemia pediatric surgery gynecologic cancers melanoma histopathology radiation therapy cancer genomics young adults medicinal research oncogenes pediatric hematology anti-cancer agents refractory solid tumors pediatric melanoma phase ii study brain tumor research tumor heterogeneity clinical radiation oncology clinical mycology cancer biology tumor targeting cancer genetics gastrointestinal oncology cytoreductive surgery reproductive medicine obstetrics and gynaecology reproductive health skin cancer pancreatic cancer drug trials ocular disease clinical pharmacology novel therapies thyroid disease pediatric patients hyperthermic intraperitoneal chemotherapy female reproductive system pharmacokinetics genomic medicine adolescence adolescent medicine oral cancer drug development neck oncology high-dose melphalan autologous stem-cell reconstitution consolidation therapy total-body irradiation childhood cancers ovarian dysgerminoma reproductive function palliative care consultation symptom assessment

Notable Scholarly Works

Notable Federal Grants

Collaborators

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors. Pediatric Blood & Cancer (2026)

pathologyurologycancer treatmentsequential cyclescancer researchoncologyradiation oncologyleukemiahematological malignanciesjama oncologyhigh‐dose chemotherapy

Surviving Childhood Cancer: The Hidden Threat of Second Malignancies. Cancer Imaging (2026)

cancer managementmalignant diseaseoncologyradiation oncologychildhood cancercancer care

Ifosfamide-Induced Encephalopathy in Children and Young Adults: The MD Anderson Cancer Center Experience. Cancers (2025)

neuropathologyifosfamide-induced encephalopathymedicinepediatricsyoung adults

Ovarian Juvenile Granulosa Cell Tumor: A Report From the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/ Dicer1 Registries. Cancer (2025)

infertilitypathologyreproductive healthanatomical pathologysurgical pathologyhistopathologyreproductive immunologycervical cancerovarian cancersarcomareproductive medicinegynecologic cancersgynecologic oncologygynecology

Retinoblastoma Patient Outcomes in the Contemporary Era: The Riverboat Consortium.. Journal of Clinical Oncology (2025)

Murali M. ChintagumpalaEmma A. SchrempTatsuki KoyamaLili SunLori Ann KehlerBruce CrooksHelen DimarasCynthia E. HerzogSandra Luna-FinemanRaj NagarajanMary Lou SchmidtCindy L. SchwartzAmish C. ShahJoanna WeinsteinAnthony DanielsJoseph Philip NegliaDebra L. Friedman

outcomes researchsurgical oncologyclinical researchgynecologic oncologycancer researchdermatologyjama oncologysurgerykidney cancerriverboat consortiumoncologyreconstructive surgerycancer riskretinoblastoma patient outcomescancer caregastrointestinal oncologyurologyspinal oncologycontemporary eraclinical mycologythoracic oncology

Supplementary Table S1 From Impact of Biomarker-Matched Therapies on Outcomes in Patients With Sarcoma Enrolled in Early-Phase Clinical Trials (Samba 101). (2025)

pathologysamba 101cancer treatmentoncologybiomarkerscancer discoveryradiation oncologybiomarker-matched therapiessarcomaprognostic biomarkersimmune checkpoint inhibitorssupplementary table s1experimental medicinejama oncology

Supplementary Tables S1-S4 From Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (Samba 102). (2025)

geneticspathologyhuman geneticsphase 1genomicssamba 102cancer researchnext-generation sequencingcancer genomicssarcomagenome biologycancer geneticssupplementary tables s1-s4molecular diagnostics

Synchronous Mediastinal Germ Cell Tumor With Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood & Cancer (2025)

acute myeloid leukemiapathologytumoral pathologyanatomical pathologysurgical pathologysarcomatous transformationoncologymalignant diseaseradiation oncologyleukemiasarcomahematological malignancies

Outcomes in Ovarian Sertoli-Leydig Cell Tumor: A Report From the International Pleuropulmonary Blastoma/Dicer1 and Ovarian and Testicular Stromal Tumor Registries. Gynecologic Oncology (2024)

Alexander T. NelsonAnne K. HarrisDave WatsonJunne KamiharaKenneth S. ChenJennifer N. StallKyle M. DevinsRobert H. YoungDamon R. OlsonPaige H.R. MallingerSarah G. MitchellLindsey M. HoffmanGail HallidayAmina M. SuleymanovaJulia L. Glade BenderYoav H. MessingerCynthia E. HerzogAmanda L. FieldA. Lindsay FrazierDouglas R. StewartLouis P. DehnerD. Ashley HillDeborah F. BillmireDominik T. SchneiderKris Ann P. Schultz

outcomes researchcancer researchoncologyovarian cancergynecologic oncologygynecology

Palbociclib and Chemotherapy Followed by Blinatumomab Consolidation to Car‐T Cell Therapy in Kmt2A‐ Rearranged, Therapy‐Related Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer (2024)

pathologymalignant blood disorderslymphoid neoplasiaoncologycancer letterhematological malignanciescell transplantationradiation oncologyleukemiaacute lymphoblastic leukemiablinatumomab consolidationcellular therapycar‐t cell therapyimmunologyimmunotherapycell therapyhematology

1
2
3
4
5
12
10 / page

Cynthia E. Herzog

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Clinical Cancer Genetics

Department Of Pediatric Research

Department Of Pediatrics Patient Care

The University of Texas MD Anderson Cancer Center

NoneCynthia E. Herzog is currently serving as a Clinical Cancer Genetics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Cynthia E. Herzog

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

pathologyurologycancer treatmentsequential cyclescancer researchoncologyradiation oncologyleukemiahematological malignanciesjama oncologyhigh‐dose chemotherapy

Surviving Childhood Cancer: The Hidden Threat of Second Malignancies. Cancer Imaging (2026)

cancer managementmalignant diseaseoncologyradiation oncologychildhood cancercancer care

Ifosfamide-Induced Encephalopathy in Children and Young Adults: The MD Anderson Cancer Center Experience. Cancers (2025)

neuropathologyifosfamide-induced encephalopathymedicinepediatricsyoung adults

Ovarian Juvenile Granulosa Cell Tumor: A Report From the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/ Dicer1 Registries. Cancer (2025)

Retinoblastoma Patient Outcomes in the Contemporary Era: The Riverboat Consortium.. Journal of Clinical Oncology (2025)

Supplementary Table S1 From Impact of Biomarker-Matched Therapies on Outcomes in Patients With Sarcoma Enrolled in Early-Phase Clinical Trials (Samba 101). (2025)

Supplementary Tables S1-S4 From Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (Samba 102). (2025)

geneticspathologyhuman geneticsphase 1genomicssamba 102cancer researchnext-generation sequencingcancer genomicssarcomagenome biologycancer geneticssupplementary tables s1-s4molecular diagnostics

Synchronous Mediastinal Germ Cell Tumor With Sarcomatous Transformation and Acute Myeloid Leukemia. Pediatric Blood & Cancer (2025)

acute myeloid leukemiapathologytumoral pathologyanatomical pathologysurgical pathologysarcomatous transformationoncologymalignant diseaseradiation oncologyleukemiasarcomahematological malignancies

Outcomes in Ovarian Sertoli-Leydig Cell Tumor: A Report From the International Pleuropulmonary Blastoma/Dicer1 and Ovarian and Testicular Stromal Tumor Registries. Gynecologic Oncology (2024)

outcomes researchcancer researchoncologyovarian cancergynecologic oncologygynecology

Palbociclib and Chemotherapy Followed by Blinatumomab Consolidation to Car‐T Cell Therapy in Kmt2A‐ Rearranged, Therapy‐Related Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer (2024)

1
2
3
4
5
12
10 / page